ARCHIVES

In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named

This article is from The Cancer Letter archive.

Vol. 07 No. 23 | June 5, 1981

Download PDF Visit The Full Archive

Related Articles

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

In Brief: FDA Deputy Commissioner Friedman Named Senior VP, Clinical Affairs, At G.D. Searle

June 16, 1999

Viral Oncology Not Losing $5 Mil. This Year – But Watch Out for ‘79

January 6, 1978

In Brief: NCA to Hear Reports On Outstanding Investigator Awards, Defining QRA, P01 Guidelines, Gallow Work

May 6, 1983

Professional Societies: ASCO Seeks Balance In Roles As U.S., International Society

May 23, 1997

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004